Your position:m.limatoxi.com >> EN >> Pharmaceutical News >> Company >> FDA cautions Aurobindo oral solids formulation facility >> article
 
FDA cautions Aurobindo oral solids formulation facility
Editor:bianch    Clicks:0    Date:2020-2-19 15:40:22
Keyword: FDA Aurobindo
Healthoo Information:
 
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
  Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
  • Aurobindo builds 2nd project at Taizhou
  • Nhwa received FDA warning Letter for 3 APIs
  • Lihua received import alert from FDA
  • Chuanning 4 APIs passed FDA authentication
  • Modern passed FDA examination
  • Huahai APIs passed FDA examination
  • Xianju passed US FDA authentication
  • Yangzhou's 7 APIs passed FDA authentication
  • Hanyu passed FDA examination first time
  • Haiteng's Dexrazoxane passed US FDA
  • Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map